Plućna bula kao faktor rizika od karcinoma pluća

Ljudmila M Nagorni-Obradović; Dragica P Pešut; Dragana Marić; Ruža S Stević

doi:10.2298/VSP150422077N

Ljudmila M Nagorni-Obradović Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Teaching Hospital of Pulmonology, Clinical Center of Serbia, Belgrade, Serbia
Dragica P Pešut Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Teaching Hospital of Pulmonology,Clinical Center of Serbia, Belgrade, Serbia
Dragana Marić Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Teaching Hospital of Pulmonology,Clinical Center of Serbia, Belgrade, Serbia
Ruža S Stević Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Centre of Radiology and Magnetic Resonance, Clinical Center of Serbia, Belgrade, Serbia

DOI: https://doi.org/10.2298/VSP150422077N

Ključne reči: lung neoplasms||, ||pluća, neoplazme, risk factors||, ||faktori rizika, bronchopneumonia||, ||bronhopneumonija, diagnosis||, ||dijagnoza, tomography, x-ray, computed||, ||tomografija, kompjuterizovana, rendgenska, disease progression||, ||bolest, progresija,

Sažetak

Uvod. Rezultati skorašnjih genetskih istraživanja ukazuju na moguću etiološku povezanost karcinoma pluća i plućne bule. Prikaz bolesnika. Bolesniku, starom 43 godine, pušaču, postavljena je dijagnoza gigantske plućne bule kada je imao 31 godinu. Praćen je pulmološki 12 godina, kada je na tom mestu otkriven karcinom pluća (adenokarcinom). U međuvremenu je lečen od ponavljanih respiratornih infekcija. Zaključak. Neophodan je aktivni pristup u praćenju bolesnika sa plućnom bulom zbog mogućeg nastanka karcinoma pluća kod tih bolesnika.

Biografije autora

Ljudmila M Nagorni-Obradović, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Teaching Hospital of Pulmonology, Clinical Center of Serbia, Belgrade, Serbia

N/A

Dragica P Pešut, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Teaching Hospital of Pulmonology,Clinical Center of Serbia, Belgrade, Serbia

N/A

Dragana Marić, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Teaching Hospital of Pulmonology,Clinical Center of Serbia, Belgrade, Serbia

N/A

Ruža S Stević, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Centre of Radiology and Magnetic Resonance, Clinical Center of Serbia, Belgrade, Serbia

N/A

Reference

Deslauriers J, Leblanc P. Bullous and Bleb Diseases, Emphysema of the Ling, and Lung Volume Reduction Operations. In: Shields TW, Lociciro J, Ponn RB, editors. General Thoracic Sur-gery. 5th ed. Philadelphia: Lippincott; 2000. p. 1001−38.

Global Initiative for Chronic Obstructive Lung Disease. NHLBI/WHO Workshop report. Available from: www.goldcopd.com [update 2011].

Snider GL. Chronic Bronchitis and Emphysema. Im: Murray JF, Nadel JA, editors. Textbook of Respiratory Medecine. Philadelphia, London, Toronto: WB Saunders; 1988. p. 1069−106.

Ogawa D, Shiota Y, Marukawa M, Hiyama J, Mashiba H, Yunoki K, et al. Lung cancer associated with pulmonary bulla. case re-port and review of literature. Respiration 1999; 66(6): 555−8.

Venuta F, Rendina EA, Pescarmona EO, De GT, Vizza D, Flaish-man I, et al. Occult lung cancer in patients with bullous emphy-sema. Thorax 1997; 52(3): 289−90.

Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008; 178(7): 738−44.

Ben-Zaken CS, Paré PD, Man PS, Sin DD. The growing burden of chronic obstructive pulmonary disease and lung cancer in women: Examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med 2007; 176(2): 113−20.

Zulueta JJ, Bloom SM, Rozansky MI, White AC. Lung cancer in patients with bullous disease. Am J Respir Crit Care Med 1996; 154(2 Pt 1): 519−22.

Sood N, Sood N. A rare case of vanishing lung syndrome. Case Rep Pulmonol 2011; 2011: 957463.

Stoloff IL, Kanofsky P, Magilner L. The risk of lung cancer in males with bullous disease of the lung. Arch Environ Health 1971; 22(1): 163−7.

Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independ-ent of age, sex and smoking history. Eur Respir J 2009;4(2): 380−6.

Watts MA, Klayton RJ, Munzel TL. Bullous emphysema and carcinoma of the lung: Case report. Mil Med 1982; 147(4): 320−3.

Lambrechts D, Buysschaert I, Zanen P, Coolen J, Lays N, Cuppens H, et al. The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with em-physema. A. J Respir Crit Care Med 2010; 181(5): 486−93.

Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic ob-structive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007; 176(3): 285−90.

Torres JP, Bastarrika G, Wisnivesky JP, Alcaide AB, Campo A, Seijo LM, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007; 132(6): 1932−8.

Lung Health Study Research Group. Effect of inhaled triamcino-lone on the decline in pulmonary function in chronic obstruc-tive pulmonary disease. N Engl J Med 2000; 343(26): 1902−9.

Young RP, Hopkins RJ, Hay BA, Epton MJ, Black PN, Gamble GD. Lung cancer gene associated with COPD: triple whammy or possible confounding effect. Eur Respir J 2008; 32(5): 1158−64.

Bechtel JJ, Kelley WA, Coons TA, Klein GM, Slagel DD, Petty TL. Lung cancer detection in patients with airflow obstruction identified in a primary care outpatient practice. Chest 2005; 127(4): 1140−5.

Torres JP, Marín JM, Casanova C, Cote C, Carrizo S, Cordoba-Lanus E, et al. Lung cancer in patients with chronic obstructive pul-monary disease: incidence and predicting factors. Am J Respir Crit Care Med 2011; 184(8): 913−9.

Gullón JA, Suárez I, Medina A, Rubinos G, Fernández R, González I. Role of emphysema and airway obstruction in prognosis of lung cancer. Lung Cancer 2011; 71(2): 182−5.

Li Y, Swensen SJ, Karabekmez LG, Marks RS, Stoddard SM, Jiang R, et al. Effect of emphysema on lung cancer risk in smokers: A computed tomography-based assessment. Cancer Rev Pres 2011; 4(1): 43−50.

Adcock IM, Caramori G, Barnes PJ. Chronic obstructive pulmo-nary disease and lung cancer: New molecular insights. Respira-tion 2011; 81(4): 265−84.

Hardavella G, Spiro S. Lung cancer in COPD. Eur Respir Monogr 2013; 59: 174−88.

Young RP, Hopkins RJ, Gamble GD, Etzel C, El-Zein R, Crapo JD. Genetic evidence linking lung cancer and COPD: A new perspective. Appl Clin Genet 2011; 4: 99−111.